000 | 01194 a2200337 4500 | ||
---|---|---|---|
005 | 20250514000859.0 | ||
264 | 0 | _c19951024 | |
008 | 199510s 0 0 eng d | ||
022 | _a0887-0292 | ||
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_aNew drug applications sought. _h[electronic resource] |
260 |
_bAIDS alert _cSep 1995 |
||
300 |
_a119-20 p. _bdigital |
||
500 | _aPublication Type: Newspaper Article; Journal Article | ||
650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xprevention & control |
650 | 0 | 4 |
_aClarithromycin _xtherapeutic use |
650 | 0 | 4 |
_aCytomegalovirus Retinitis _xcomplications |
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aDrug Implants |
650 | 0 | 4 | _aDrug Labeling |
650 | 0 | 4 |
_aFoscarnet _xtherapeutic use |
650 | 0 | 4 |
_aGanciclovir _xadministration & dosage |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHerpes Simplex _xcomplications |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aMycobacterium avium-intracellulare Infection _xcomplications |
650 | 0 | 4 |
_aStavudine _xtherapeutic use |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
773 | 0 |
_tAIDS alert _gvol. 10 _gno. 9 _gp. 119-20 |
|
999 |
_c11294785 _d11294785 |